

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.95642433 |
| 2 | actin-mediated cell contraction (GO:0070252) | 8.87534087 |
| 3 | sarcomere organization (GO:0045214) | 8.47620331 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.29134895 |
| 5 | skeletal muscle contraction (GO:0003009) | 7.92840904 |
| 6 | myofibril assembly (GO:0030239) | 7.35250699 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.26327694 |
| 8 | plasma membrane repair (GO:0001778) | 7.19099942 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.85562834 |
| 10 | skeletal muscle adaptation (GO:0043501) | 6.84404844 |
| 11 | actin filament-based movement (GO:0030048) | 6.64635959 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.45534162 |
| 13 | striated muscle contraction (GO:0006941) | 6.45342583 |
| 14 | cardiac myofibril assembly (GO:0055003) | 6.37573019 |
| 15 | carnitine shuttle (GO:0006853) | 5.91613228 |
| 16 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.89945236 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.72116304 |
| 18 | cardiac muscle contraction (GO:0060048) | 5.71564194 |
| 19 | regulation of cell communication by electrical coupling (GO:0010649) | 5.64900073 |
| 20 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.60716314 |
| 21 | actomyosin structure organization (GO:0031032) | 5.58511565 |
| 22 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.35690436 |
| 23 | tricarboxylic acid cycle (GO:0006099) | 5.35203042 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.32206692 |
| 25 | * creatine metabolic process (GO:0006600) | 5.23084593 |
| 26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.13518981 |
| 27 | fatty acid transmembrane transport (GO:1902001) | 5.05904141 |
| 28 | glycogen catabolic process (GO:0005980) | 5.03196873 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 5.02163058 |
| 30 | cardiac muscle cell development (GO:0055013) | 4.96096956 |
| 31 | muscle contraction (GO:0006936) | 4.88388830 |
| 32 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.87293325 |
| 33 | skeletal muscle fiber development (GO:0048741) | 4.78766009 |
| 34 | glucan catabolic process (GO:0009251) | 4.70098964 |
| 35 | cardiac cell development (GO:0055006) | 4.65038533 |
| 36 | response to inactivity (GO:0014854) | 4.63997976 |
| 37 | skeletal muscle tissue development (GO:0007519) | 4.61998978 |
| 38 | striated muscle adaptation (GO:0014888) | 4.55299631 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.54765062 |
| 40 | striated muscle atrophy (GO:0014891) | 4.53393687 |
| 41 | skeletal muscle tissue regeneration (GO:0043403) | 4.53055487 |
| 42 | response to muscle activity (GO:0014850) | 4.51067079 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.48162873 |
| 44 | muscle system process (GO:0003012) | 4.44475548 |
| 45 | regulation of coenzyme metabolic process (GO:0051196) | 4.41346335 |
| 46 | regulation of cofactor metabolic process (GO:0051193) | 4.41346335 |
| 47 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.40982161 |
| 48 | carnitine transmembrane transport (GO:1902603) | 4.38298909 |
| 49 | cellular polysaccharide catabolic process (GO:0044247) | 4.37729515 |
| 50 | heart process (GO:0003015) | 4.34255645 |
| 51 | heart contraction (GO:0060047) | 4.34255645 |
| 52 | cytidine catabolic process (GO:0006216) | 4.22399061 |
| 53 | cytidine deamination (GO:0009972) | 4.22399061 |
| 54 | cytidine metabolic process (GO:0046087) | 4.22399061 |
| 55 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.21234727 |
| 56 | polysaccharide catabolic process (GO:0000272) | 4.18235366 |
| 57 | adult heart development (GO:0007512) | 4.13746689 |
| 58 | striated muscle hypertrophy (GO:0014897) | 4.12642273 |
| 59 | cardiac muscle hypertrophy (GO:0003300) | 4.10858819 |
| 60 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.10627010 |
| 61 | muscle fiber development (GO:0048747) | 4.10378959 |
| 62 | myotube cell development (GO:0014904) | 4.10343218 |
| 63 | positive regulation of myotube differentiation (GO:0010831) | 4.06168553 |
| 64 | muscle tissue morphogenesis (GO:0060415) | 4.05217221 |
| 65 | glucan biosynthetic process (GO:0009250) | 4.03152903 |
| 66 | glycogen biosynthetic process (GO:0005978) | 4.03152903 |
| 67 | regulation of membrane repolarization (GO:0060306) | 4.01583763 |
| 68 | amino-acid betaine transport (GO:0015838) | 3.99126980 |
| 69 | carnitine transport (GO:0015879) | 3.99126980 |
| 70 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.99002121 |
| 71 | regulation of sarcomere organization (GO:0060297) | 3.98754341 |
| 72 | muscle cell fate commitment (GO:0042693) | 3.93649358 |
| 73 | striated muscle cell development (GO:0055002) | 3.93619994 |
| 74 | muscle atrophy (GO:0014889) | 3.87801033 |
| 75 | fructose metabolic process (GO:0006000) | 3.87301212 |
| 76 | regulation of the force of heart contraction (GO:0002026) | 3.83851175 |
| 77 | muscle organ development (GO:0007517) | 3.81406106 |
| 78 | muscle organ morphogenesis (GO:0048644) | 3.81123885 |
| 79 | muscle structure development (GO:0061061) | 3.80727126 |
| 80 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.80427131 |
| 81 | gluconeogenesis (GO:0006094) | 3.78246051 |
| 82 | muscle adaptation (GO:0043500) | 3.77612862 |
| 83 | response to activity (GO:0014823) | 3.75680059 |
| 84 | negative regulation of muscle hypertrophy (GO:0014741) | 3.74483952 |
| 85 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.69016060 |
| 86 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.69016060 |
| 87 | heart trabecula formation (GO:0060347) | 3.66245526 |
| 88 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.63958582 |
| 89 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.63958582 |
| 90 | muscle hypertrophy (GO:0014896) | 3.63907253 |
| 91 | regulation of sulfur metabolic process (GO:0042762) | 3.60009594 |
| 92 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53944635 |
| 93 | glycogen metabolic process (GO:0005977) | 3.52647055 |
| 94 | NADH metabolic process (GO:0006734) | 3.51408015 |
| 95 | glucan metabolic process (GO:0044042) | 3.45287865 |
| 96 | cellular glucan metabolic process (GO:0006073) | 3.45287865 |
| 97 | regulation of sequestering of triglyceride (GO:0010889) | 3.44113304 |
| 98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.38946033 |
| 99 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.38776674 |
| 100 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.38648531 |
| 101 | myoblast fusion (GO:0007520) | 3.38336424 |
| 102 | hexose biosynthetic process (GO:0019319) | 3.37181910 |
| 103 | muscle cell development (GO:0055001) | 3.36693893 |
| 104 | negative regulation of protein localization to cell surface (GO:2000009) | 3.35612580 |
| 105 | regulation of myoblast differentiation (GO:0045661) | 3.34105483 |
| 106 | muscle cell cellular homeostasis (GO:0046716) | 3.33693195 |
| 107 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.32108304 |
| 108 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.31529286 |
| 109 | positive regulation of cation channel activity (GO:2001259) | 3.31090533 |
| 110 | regulation of muscle system process (GO:0090257) | 3.29383485 |
| 111 | neuronal action potential propagation (GO:0019227) | 3.28912046 |
| 112 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.28465606 |
| 113 | muscle hypertrophy in response to stress (GO:0003299) | 3.28465606 |
| 114 | cardiac muscle adaptation (GO:0014887) | 3.28465606 |
| 115 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.27452103 |
| 116 | relaxation of muscle (GO:0090075) | 3.25760171 |
| 117 | striated muscle tissue development (GO:0014706) | 3.24968447 |
| 118 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.24580949 |
| 119 | regulation of muscle contraction (GO:0006937) | 3.24299899 |
| 120 | negative regulation of potassium ion transport (GO:0043267) | 3.22963740 |
| 121 | oxidative phosphorylation (GO:0006119) | 3.22239786 |
| 122 | regulation of ATPase activity (GO:0043462) | 3.21738368 |
| 123 | muscle filament sliding (GO:0030049) | 10.8047303 |
| 124 | actin-myosin filament sliding (GO:0033275) | 10.8047303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10054211 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.62694082 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.83483081 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.71292490 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.48228450 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.48228450 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.38566383 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.25336969 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.14607557 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70725802 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.57411361 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.40142000 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25071364 |
| 14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.08183879 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05161980 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03874485 |
| 17 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.82525788 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81170095 |
| 19 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.79278268 |
| 20 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.78492939 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77867529 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72524525 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71253641 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.70443599 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69626691 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.60523337 |
| 27 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.58754506 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.57304791 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55062718 |
| 30 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.49697440 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.48039815 |
| 32 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.47357055 |
| 33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44900625 |
| 34 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42675535 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40025085 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.36573004 |
| 37 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.35658340 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33537912 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33043750 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32462346 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28251553 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27737475 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25198969 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24500723 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23945135 |
| 46 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21309416 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20646642 |
| 48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20540238 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19447511 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18757952 |
| 51 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.18747812 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17068329 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15589582 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15062630 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14958938 |
| 56 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.14613791 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14116119 |
| 58 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12169942 |
| 59 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10398841 |
| 60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09007779 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08343033 |
| 62 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.08258203 |
| 63 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07715488 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07698314 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06779710 |
| 66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06529877 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05399522 |
| 68 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05029985 |
| 69 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03548011 |
| 70 | * P68_20966046_ChIP-Seq_HELA_Human | 1.01740896 |
| 71 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.01653108 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01360322 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01303177 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01232299 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99938813 |
| 76 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99647599 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99207459 |
| 78 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99115906 |
| 79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98630216 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97988046 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97900899 |
| 82 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97163514 |
| 83 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.95798132 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95214113 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94234292 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93525063 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93508706 |
| 88 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93093011 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92083491 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91686617 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91632227 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91489437 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91170286 |
| 94 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89712781 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87711121 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87598467 |
| 97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87418427 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87291219 |
| 99 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86455861 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86294896 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85354782 |
| 102 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.85289433 |
| 103 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84437184 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83780859 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83502303 |
| 106 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83066983 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83036468 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82892802 |
| 109 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82842378 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82680022 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82060755 |
| 112 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81675753 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81202709 |
| 114 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.81060270 |
| 115 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.80817275 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80415158 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80057054 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80017423 |
| 119 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.79202956 |
| 120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78987232 |
| 121 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.78712707 |
| 122 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78629715 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78336179 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77935924 |
| 125 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77922356 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76923485 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76423362 |
| 128 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.76198579 |
| 129 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76069099 |
| 130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.75944230 |
| 131 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.75034894 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74588873 |
| 133 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.73116983 |
| 134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71783549 |
| 135 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.71771356 |
| 136 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71168501 |
| 137 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.70024271 |
| 138 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.68983355 |
| 139 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.67466286 |
| 140 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.67363050 |
| 141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66703869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.42011483 |
| 2 | MP0000751_myopathy | 5.78977166 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 5.57835184 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 5.47097608 |
| 5 | MP0000749_muscle_degeneration | 5.46826493 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.47486973 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.93290731 |
| 8 | * MP0002106_abnormal_muscle_physiology | 3.50488570 |
| 9 | MP0000747_muscle_weakness | 3.48389065 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.46899880 |
| 11 | MP0004215_abnormal_myocardial_fiber | 3.23634941 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.20527505 |
| 13 | MP0004130_abnormal_muscle_cell | 3.13009141 |
| 14 | MP0005330_cardiomyopathy | 3.08832016 |
| 15 | MP0002269_muscular_atrophy | 3.07493690 |
| 16 | * MP0005620_abnormal_muscle_contractility | 3.03520785 |
| 17 | * MP0000759_abnormal_skeletal_muscle | 3.02626199 |
| 18 | * MP0005369_muscle_phenotype | 2.90456399 |
| 19 | MP0004233_abnormal_muscle_weight | 2.24536975 |
| 20 | * MP0002972_abnormal_cardiac_muscle | 2.22686726 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.00465418 |
| 22 | MP0004484_altered_response_of | 1.96143303 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.94494278 |
| 24 | MP0003137_abnormal_impulse_conducting | 1.92322592 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 1.85586315 |
| 26 | MP0005385_cardiovascular_system_phenoty | 1.85586315 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.81937168 |
| 28 | MP0000733_abnormal_muscle_development | 1.64841145 |
| 29 | * MP0006036_abnormal_mitochondrial_physio | 1.64200066 |
| 30 | MP0002108_abnormal_muscle_morphology | 1.62169536 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59474273 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.55624817 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.52748225 |
| 34 | MP0006138_congestive_heart_failure | 1.49367033 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.39331282 |
| 36 | MP0003828_pulmonary_edema | 1.31346926 |
| 37 | MP0004085_abnormal_heartbeat | 1.22796310 |
| 38 | MP0005275_abnormal_skin_tensile | 1.15201828 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.13439420 |
| 40 | MP0002127_abnormal_cardiovascular_syste | 1.11267252 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.07351904 |
| 42 | MP0004510_myositis | 1.06614255 |
| 43 | MP0002971_abnormal_brown_adipose | 1.04283585 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.03670280 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.01817385 |
| 46 | MP0005670_abnormal_white_adipose | 0.99121532 |
| 47 | MP0000013_abnormal_adipose_tissue | 0.96364548 |
| 48 | MP0005266_abnormal_metabolism | 0.96189843 |
| 49 | MP0001661_extended_life_span | 0.94764163 |
| 50 | MP0000343_altered_response_to | 0.93075020 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 0.88869578 |
| 52 | MP0002822_catalepsy | 0.85563311 |
| 53 | * MP0000266_abnormal_heart_morphology | 0.84226097 |
| 54 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77599314 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.74092957 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.67983258 |
| 57 | MP0004147_increased_porphyrin_level | 0.62874074 |
| 58 | MP0004043_abnormal_pH_regulation | 0.61289075 |
| 59 | MP0005165_increased_susceptibility_to | 0.59836679 |
| 60 | MP0008961_abnormal_basal_metabolism | 0.57812482 |
| 61 | MP0000372_irregular_coat_pigmentation | 0.53941247 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 0.53934241 |
| 63 | MP0003279_aneurysm | 0.52088480 |
| 64 | * MP0002078_abnormal_glucose_homeostasis | 0.50267751 |
| 65 | MP0004270_analgesia | 0.50082264 |
| 66 | MP0003879_abnormal_hair_cell | 0.49184667 |
| 67 | MP0005334_abnormal_fat_pad | 0.47386196 |
| 68 | * MP0002128_abnormal_blood_circulation | 0.47148565 |
| 69 | MP0010368_abnormal_lymphatic_system | 0.44284613 |
| 70 | MP0005451_abnormal_body_composition | 0.43861058 |
| 71 | MP0000579_abnormal_nail_morphology | 0.42931512 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.42755903 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.42252008 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.41789298 |
| 75 | MP0000762_abnormal_tongue_morphology | 0.41204439 |
| 76 | * MP0000230_abnormal_systemic_arterial | 0.40933878 |
| 77 | MP0010030_abnormal_orbit_morphology | 0.40238749 |
| 78 | MP0001879_abnormal_lymphatic_vessel | 0.38612723 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.37961409 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.37669066 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.37424811 |
| 82 | MP0001299_abnormal_eye_distance/ | 0.37131453 |
| 83 | MP0003045_fibrosis | 0.35617030 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.35207648 |
| 85 | MP0004142_abnormal_muscle_tone | 0.34603774 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.33854586 |
| 87 | MP0002796_impaired_skin_barrier | 0.32872746 |
| 88 | MP0005452_abnormal_adipose_tissue | 0.32852549 |
| 89 | MP0003948_abnormal_gas_homeostasis | 0.32809356 |
| 90 | MP0005166_decreased_susceptibility_to | 0.32383050 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.32230794 |
| 92 | MP0005083_abnormal_biliary_tract | 0.31011538 |
| 93 | MP0002114_abnormal_axial_skeleton | 0.30874363 |
| 94 | MP0004134_abnormal_chest_morphology | 0.30447318 |
| 95 | MP0009115_abnormal_fat_cell | 0.30174814 |
| 96 | MP0005535_abnormal_body_temperature | 0.29149971 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.28871152 |
| 98 | MP0008569_lethality_at_weaning | 0.28740272 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.28413465 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 0.28121076 |
| 101 | MP0005187_abnormal_penis_morphology | 0.27434402 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.27392635 |
| 103 | MP0005332_abnormal_amino_acid | 0.27275245 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.26920243 |
| 105 | MP0002925_abnormal_cardiovascular_devel | 0.26301214 |
| 106 | MP0004272_abnormal_basement_membrane | 0.24908531 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.24055239 |
| 108 | MP0001784_abnormal_fluid_regulation | 0.23803983 |
| 109 | MP0003959_abnormal_lean_body | 0.23454635 |
| 110 | MP0009672_abnormal_birth_weight | 0.21571883 |
| 111 | MP0001943_abnormal_respiration | 0.21333044 |
| 112 | MP0001614_abnormal_blood_vessel | 0.20443129 |
| 113 | MP0001853_heart_inflammation | 0.20384403 |
| 114 | MP0002066_abnormal_motor_capabilities/c | 0.19811488 |
| 115 | MP0005423_abnormal_somatic_nervous | 0.19790783 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.19299934 |
| 117 | MP0002970_abnormal_white_adipose | 0.18024038 |
| 118 | MP0002249_abnormal_larynx_morphology | 0.14863476 |
| 119 | MP0008874_decreased_physiological_sensi | 0.14124740 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.13205962 |
| 121 | MP0004924_abnormal_behavior | 0.13205962 |
| 122 | MP0006276_abnormal_autonomic_nervous | 0.12840712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 8.36198631 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.80709435 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 7.71287851 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.45344867 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.93463496 |
| 6 | Nemaline bodies (HP:0003798) | 6.82029857 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.64125880 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 6.24952096 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.99880676 |
| 10 | Distal arthrogryposis (HP:0005684) | 5.63183782 |
| 11 | Myoglobinuria (HP:0002913) | 5.54414739 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 5.37065709 |
| 13 | Sudden death (HP:0001699) | 5.34069950 |
| 14 | Difficulty running (HP:0009046) | 5.08453030 |
| 15 | Myopathic facies (HP:0002058) | 4.99896655 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 4.95257463 |
| 17 | Round ear (HP:0100830) | 4.83358510 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.81825739 |
| 19 | Increased connective tissue (HP:0009025) | 4.73491720 |
| 20 | Subaortic stenosis (HP:0001682) | 4.68896713 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.68896713 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.50052687 |
| 23 | Ulnar deviation of the wrist (HP:0003049) | 4.49133426 |
| 24 | Ventricular tachycardia (HP:0004756) | 4.22770251 |
| 25 | Myotonia (HP:0002486) | 4.22404663 |
| 26 | Muscle stiffness (HP:0003552) | 4.20990512 |
| 27 | Calcaneovalgus deformity (HP:0001848) | 3.78308148 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.72239903 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.64629769 |
| 30 | Deformed tarsal bones (HP:0008119) | 3.55526568 |
| 31 | Absent phalangeal crease (HP:0006109) | 3.50404335 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.45059173 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.43968742 |
| 34 | Neck muscle weakness (HP:0000467) | 3.42676954 |
| 35 | Lipoatrophy (HP:0100578) | 3.29377414 |
| 36 | Rimmed vacuoles (HP:0003805) | 3.17407170 |
| 37 | Areflexia of lower limbs (HP:0002522) | 3.12630761 |
| 38 | Atrial fibrillation (HP:0005110) | 3.04870238 |
| 39 | Right ventricular cardiomyopathy (HP:0011663) | 2.93214297 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 2.89508239 |
| 41 | Abnormal finger flexion creases (HP:0006143) | 2.87941863 |
| 42 | Primary atrial arrhythmia (HP:0001692) | 2.84125573 |
| 43 | Frequent falls (HP:0002359) | 2.82295016 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.79041841 |
| 45 | Supraventricular tachycardia (HP:0004755) | 2.73913929 |
| 46 | Bundle branch block (HP:0011710) | 2.72912569 |
| 47 | Supraventricular arrhythmia (HP:0005115) | 2.68560797 |
| 48 | Palpitations (HP:0001962) | 2.63061921 |
| 49 | Malignant hyperthermia (HP:0002047) | 2.59088847 |
| 50 | EMG: neuropathic changes (HP:0003445) | 2.53692003 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.50413492 |
| 52 | Prolonged QT interval (HP:0001657) | 2.47429424 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.46396832 |
| 54 | Ventricular arrhythmia (HP:0004308) | 2.44015011 |
| 55 | Limb-girdle muscle atrophy (HP:0003797) | 2.37262012 |
| 56 | Muscular dystrophy (HP:0003560) | 2.37096820 |
| 57 | Syncope (HP:0001279) | 2.36728859 |
| 58 | Generalized muscle weakness (HP:0003324) | 2.32439905 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.28002308 |
| 60 | Hyperkalemia (HP:0002153) | 2.27878152 |
| 61 | Heart block (HP:0012722) | 2.26681021 |
| 62 | Hip contracture (HP:0003273) | 2.21758818 |
| 63 | Abnormality of the neuromuscular junction (HP:0003398) | 2.21094327 |
| 64 | Fatigable weakness (HP:0003473) | 2.21094327 |
| 65 | Facial diplegia (HP:0001349) | 2.20731673 |
| 66 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.19692067 |
| 67 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.19692067 |
| 68 | Lower limb amyotrophy (HP:0007210) | 2.19431542 |
| 69 | Abnormality of the calcaneus (HP:0008364) | 2.18804860 |
| 70 | Pelvic girdle muscle weakness (HP:0003749) | 2.18267587 |
| 71 | Scapular winging (HP:0003691) | 2.16874480 |
| 72 | Shoulder girdle muscle weakness (HP:0003547) | 2.16806343 |
| 73 | Abnormal atrioventricular conduction (HP:0005150) | 2.15785209 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.15689406 |
| 75 | Gowers sign (HP:0003391) | 2.15674971 |
| 76 | Proximal amyotrophy (HP:0007126) | 2.12123516 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.11972149 |
| 78 | Spinal rigidity (HP:0003306) | 2.11078140 |
| 79 | Limb-girdle muscle weakness (HP:0003325) | 2.10292472 |
| 80 | Slender build (HP:0001533) | 2.07476641 |
| 81 | Waddling gait (HP:0002515) | 2.05858878 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.05276578 |
| 83 | Bulbar palsy (HP:0001283) | 2.02346492 |
| 84 | Ventricular fibrillation (HP:0001663) | 1.99235511 |
| 85 | Abnormality of the ischium (HP:0003174) | 1.98513152 |
| 86 | Atrioventricular block (HP:0001678) | 1.96536628 |
| 87 | Progressive muscle weakness (HP:0003323) | 1.96306818 |
| 88 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92361065 |
| 89 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.84123742 |
| 90 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.83922473 |
| 91 | Paralysis (HP:0003470) | 1.83885655 |
| 92 | Left ventricular hypertrophy (HP:0001712) | 1.81165225 |
| 93 | Exercise intolerance (HP:0003546) | 1.80790880 |
| 94 | Abnormal EKG (HP:0003115) | 1.80641015 |
| 95 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79425218 |
| 96 | Weak cry (HP:0001612) | 1.77343072 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 1.74632716 |
| 98 | Foot dorsiflexor weakness (HP:0009027) | 1.72921247 |
| 99 | Acute necrotizing encephalopathy (HP:0006965) | 1.72841698 |
| 100 | Popliteal pterygium (HP:0009756) | 1.71829167 |
| 101 | Ketoacidosis (HP:0001993) | 1.69632041 |
| 102 | Conjunctival hamartoma (HP:0100780) | 1.69551711 |
| 103 | Palmoplantar keratoderma (HP:0000982) | 1.69131306 |
| 104 | Hepatic necrosis (HP:0002605) | 1.67999730 |
| 105 | Cholelithiasis (HP:0001081) | 1.66549708 |
| 106 | Metatarsus adductus (HP:0001840) | 1.66283840 |
| 107 | Increased muscle lipid content (HP:0009058) | 1.65121970 |
| 108 | Testicular atrophy (HP:0000029) | 1.64856535 |
| 109 | Increased intramyocellular lipid droplets (HP:0012240) | 1.61884026 |
| 110 | Nonprogressive disorder (HP:0003680) | 1.57488776 |
| 111 | Type 2 muscle fiber atrophy (HP:0003554) | 1.56005889 |
| 112 | Long clavicles (HP:0000890) | 1.53060949 |
| 113 | Ulnar deviation of finger (HP:0009465) | 1.50219612 |
| 114 | Limited hip movement (HP:0008800) | 1.47714906 |
| 115 | Muscle fiber atrophy (HP:0100295) | 1.45959967 |
| 116 | Steppage gait (HP:0003376) | 1.35311220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.14138536 |
| 2 | TTN | 6.65133833 |
| 3 | PHKG1 | 5.41719201 |
| 4 | PHKG2 | 5.41719201 |
| 5 | NME1 | 2.77634636 |
| 6 | PDK4 | 2.74615724 |
| 7 | PDK3 | 2.74615724 |
| 8 | TRIB3 | 2.49278465 |
| 9 | DMPK | 2.49014927 |
| 10 | NEK1 | 2.48076658 |
| 11 | PIK3CG | 2.43002250 |
| 12 | MAP2K3 | 2.15673223 |
| 13 | PINK1 | 2.13259793 |
| 14 | PIK3CA | 2.09664427 |
| 15 | BCKDK | 2.04263614 |
| 16 | MUSK | 1.90196596 |
| 17 | PKN2 | 1.84781561 |
| 18 | MAP3K7 | 1.77571882 |
| 19 | PDK2 | 1.73547275 |
| 20 | LMTK2 | 1.63848534 |
| 21 | MYLK | 1.58379570 |
| 22 | MAPK12 | 1.46620918 |
| 23 | STK24 | 1.34049142 |
| 24 | TIE1 | 1.21380844 |
| 25 | MAPKAPK3 | 1.08965068 |
| 26 | MARK1 | 1.02282810 |
| 27 | MAP2K4 | 0.99056611 |
| 28 | MAP3K3 | 0.93501968 |
| 29 | MOS | 0.93334334 |
| 30 | PRKAA2 | 0.92155322 |
| 31 | PRKAA1 | 0.91038177 |
| 32 | MAP2K6 | 0.89666116 |
| 33 | ILK | 0.84727898 |
| 34 | TRPM7 | 0.82200292 |
| 35 | CCNB1 | 0.81527904 |
| 36 | RIPK1 | 0.76322945 |
| 37 | DYRK1B | 0.73978503 |
| 38 | NEK9 | 0.72459514 |
| 39 | PRKD1 | 0.72308459 |
| 40 | ZAK | 0.69530543 |
| 41 | EPHB1 | 0.64661834 |
| 42 | MAP3K13 | 0.61901919 |
| 43 | CAMK2D | 0.60652465 |
| 44 | ROCK1 | 0.60300791 |
| 45 | MAP3K5 | 0.59731044 |
| 46 | SIK1 | 0.55449199 |
| 47 | AKT2 | 0.52425397 |
| 48 | GRK7 | 0.52077338 |
| 49 | PAK3 | 0.51592512 |
| 50 | CAMK2G | 0.50750007 |
| 51 | PKN1 | 0.49293404 |
| 52 | INSRR | 0.44922343 |
| 53 | MAPK11 | 0.44788302 |
| 54 | TAOK1 | 0.44480983 |
| 55 | CAMK2B | 0.43753468 |
| 56 | PTK6 | 0.42327670 |
| 57 | MAP3K11 | 0.40843658 |
| 58 | TGFBR2 | 0.39972136 |
| 59 | TAOK2 | 0.39380393 |
| 60 | PRKACB | 0.39115583 |
| 61 | FLT3 | 0.38516646 |
| 62 | PDGFRA | 0.32762745 |
| 63 | CDC42BPA | 0.30521268 |
| 64 | TBK1 | 0.30362851 |
| 65 | ROCK2 | 0.30163217 |
| 66 | PRKACA | 0.29284068 |
| 67 | CAMK4 | 0.28430026 |
| 68 | STK38L | 0.28108930 |
| 69 | PDPK1 | 0.28078525 |
| 70 | SGK1 | 0.26475066 |
| 71 | SGK2 | 0.25980924 |
| 72 | PTK2B | 0.25271367 |
| 73 | ICK | 0.25038515 |
| 74 | EEF2K | 0.24886736 |
| 75 | MAP3K1 | 0.24789852 |
| 76 | PRPF4B | 0.24744270 |
| 77 | STK38 | 0.24245953 |
| 78 | PRKG1 | 0.23399887 |
| 79 | ERBB3 | 0.23047128 |
| 80 | CAMK2A | 0.22165757 |
| 81 | MAPK10 | 0.22142883 |
| 82 | RPS6KB1 | 0.21976066 |
| 83 | PDK1 | 0.21872334 |
| 84 | ARAF | 0.21562877 |
| 85 | PRKACG | 0.20650686 |
| 86 | RPS6KA3 | 0.20143215 |
| 87 | RPS6KB2 | 0.20056899 |
| 88 | LATS1 | 0.19677742 |
| 89 | MAPK13 | 0.19092264 |
| 90 | MAPK7 | 0.18920255 |
| 91 | DAPK3 | 0.18272586 |
| 92 | RPS6KA1 | 0.17831829 |
| 93 | FER | 0.17498850 |
| 94 | RPS6KL1 | 0.17468218 |
| 95 | RPS6KC1 | 0.17468218 |
| 96 | MAP3K10 | 0.16608550 |
| 97 | STK4 | 0.16584706 |
| 98 | MARK2 | 0.16229479 |
| 99 | WNK1 | 0.16035981 |
| 100 | CAMK1 | 0.15459067 |
| 101 | LIMK1 | 0.15065206 |
| 102 | KDR | 0.14629995 |
| 103 | LATS2 | 0.14427671 |
| 104 | LRRK2 | 0.13859527 |
| 105 | MAP3K6 | 0.13625953 |
| 106 | MAPK4 | 0.13485114 |
| 107 | MTOR | 0.13028710 |
| 108 | RPS6KA6 | 0.12170735 |
| 109 | ZAP70 | 0.12052201 |
| 110 | WNK4 | 0.11956346 |
| 111 | CDK19 | 0.11870447 |
| 112 | ERN1 | 0.11662280 |
| 113 | KSR2 | 0.11311630 |
| 114 | MAP2K1 | 0.10736869 |
| 115 | EPHA3 | 0.10280649 |
| 116 | SGK3 | 0.10248940 |
| 117 | CAMK1G | 0.09946865 |
| 118 | DAPK2 | 0.09686844 |
| 119 | RAF1 | 0.09543292 |
| 120 | RET | 0.09524854 |
| 121 | SGK494 | 0.08628054 |
| 122 | SGK223 | 0.08628054 |
| 123 | MARK3 | 0.07560707 |
| 124 | BRAF | 0.07198155 |
| 125 | STK11 | 0.06141753 |
| 126 | NLK | 0.05180336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.37053534 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.13538890 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.08124563 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.03417299 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.76417031 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.14759858 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.92599536 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83027720 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.60508175 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.42613733 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.40144521 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34109442 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.10640162 |
| 14 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.98350773 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96922901 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90717427 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.81890146 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74211829 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69845993 |
| 20 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.67542120 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.65280115 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64561250 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.62165673 |
| 24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.58426522 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43169801 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.42126726 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36871962 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29880699 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26598986 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21937081 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21863664 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.19419929 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16958869 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10772692 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.03639154 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 0.95643245 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 0.93891041 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93773375 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93510406 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92535816 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86814567 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86621808 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85513443 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77733485 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77530135 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74053422 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72308247 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70799833 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70306420 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65438265 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64620490 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64388409 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62705824 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.57296286 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56296922 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55074484 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51571111 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51000975 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46902292 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46154010 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45444751 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43874455 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.43468269 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.42820359 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41891726 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.41197069 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40482830 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.40344862 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40025568 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39707974 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39642931 |
| 72 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38037276 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.36774171 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35013112 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33203650 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33173432 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.32904595 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31477829 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31473732 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28052939 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27684503 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27011745 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.26474367 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26337425 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25085852 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24203476 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23516823 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21046779 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20122493 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17938235 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.17279062 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16475737 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16304046 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.15190890 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.14897088 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14653032 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.14257052 |
| 98 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.13762198 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.12155458 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.10712222 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.10587538 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09457307 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.07727503 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06827743 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06266127 |
| 106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.05086281 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.04713272 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04324145 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.03872677 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.03578886 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03438232 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.02232153 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.01056221 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.00994283 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.00963150 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | -0.0098485 |

